The Dow Chemical Company

VISIT THE VIRTUAL BOOTH, Contact Details

DIGITAL CONTENT

Interview #SpeakPharma, Vlog #PharmaReel, Data Compilation #PharmaFlow, 27 News #PharmaBuzz

ACTIVE PHARMA INGREDIENTS

98 All APIs, 94 USDMF, 9 JDMF

EXCIPIENTS

59 All Excipients, 51 USDMF, 3 CEP/COS, 1 JDMF, 2 KDMF, 6 NDC API, 6 Listed Products

EXCIPIENTS BY INGREDIENTS

Hydroxypropyl methylcellulose acetate succinate, Carboxymethyl cellulose sodium, Hypromellose Acetate Succinate, Hydroxypropyl Methylcellulose, Hydroxypropyl Methyl Cellulose, EthylCellulose

EXCIPIENTS BY APPLICATIONS

Coating Systems & Additives, Controlled & Modified Release, Granulation, Rheology Modifiers, Solubilizers, API Stability Enhancers, Direct Compression, Taste Masking, Vegetarian Capsules

REF. STANDARDS & IMPURITIES

1 Others

1 Others

INSPECTIONS & REGISTRATIONS

20 FDA, 4 EDQM, 2 GDUFA

Filters

Digital content

Create Content with PharmaCompass, ask us

INTERVIEW #SpeakPharma

[Sponsored by another company]

“Over 500 million syringes of our hyaluronic acid have been safely used worldwide”

This week, SpeakPharma interviews Marie-Armelle Floc’h, Chief of Quality and Regulatory Affairs at HTL Biotechnology, a global leader in the development and the manufacturing of pharmaceutical-grade biopolymers headquartered in Javené, Brittany (France). Since 1992, HTL has pioneered the production of hyaluronic acid (HA) through proprietary biofermentation, achieving unmatched purity and consistency for applications in ophthalmology, dermatology and rheumatology. Floc’h highlights how HTL Biotechnology’s compelling portfolio of pharmaceutical-grade biopolymers is built on uncompromising quality standards. These standards have enabled the company to supply biopolymers for over 30 years without a single batch recall, firmly establishing its reputation for reliability and excellence. She also discusses the inauguration of HTL Biotechnology’s new sterile hyaluronic acid production unit — a major milestone that reinforces the company’s leadership in biopolymer manufacturing and enables the development of innovative formulations combining hyaluronic acid with thermo-sensitive active ingredients. This new capability opens the door to advanced biomedical applications where safety, stability and efficacy must be preserved without compromising the integrity of delicate molecules and which requires the highest quality standards. What distinguishes HTL Biotechnology’s biopolymer platforms in the market today? HTL Biotechnology has built its reputation on delivering pharmaceutical‑grade biopolymers (hyaluronic acid, polynucleotides and recombinant collagen) with unmatched purity and consistency. Since its founding in 1992, the company has focused on premium quality positioning. With more than 30 years of experience, HTL Biotechnology guarantees pharmaceutical-grade biopolymers of exceptional purity and exemplary consistency to our clients. We have had no batch recalls in 30 years, a record that underlines the rigor and reliability embedded in our processes. This was made possible by our fully-integrated site in France, where R&D laboratories, GMP manufacturing, quality control, and regulatory expertise are brought together under one roof. Such integration allows us to support our clients seamlessly throughout their product development journey, from early innovation through to global commercialization.Also, the inauguration of our new sterile hyaluronic acid production unit expands the possibilities for our HA to be used in advanced formulations with thermo-sensitive active ingredients, while upholding the uncompromising quality that defines HTL Biotechnology.Our operations are guided by internationally recognized standards, including ISO 13485 certification, which ensures the quality and safety required by medical device manufacturers worldwide.In addition, our Halal certification provides our customers with a significant advantage in accessing and expanding into markets where these requirements are essential for commercialization.Beyond certifications, our commitment to supporting global growth is reflected in the Drug Master Files we maintain across five continents, enabling our clients to accelerate product registration and bring innovative therapies to markets across the world more efficiently. By combining craftsmanship with pharmaceutical rigor, supported by state-of-the-art equipment and advanced bio-production methods, we ensure that every batch produced not only meets the strictest standards, but also delivers the reliability and consistency needed across the entire healthcare ecosystem. HIGHLIGHTS// Biopolymers with unmatched purity/record of no batch recalls/integrated facility in France/operations guided by global standards/new sterile HA unit for advanced formulations Navigating the complex and evolving regulatory frameworks across global markets can be challenging for healthcare companies. Can you tell us more about how HTL Biotechnology supports its partners in this area? Regulatory support is part of our core premium services offer. We provide pharmaceutical regulatory support to ensure products meet the necessary compliance standards, so our partners can focus on their growth. Our dedicated regulatory professionals bring global and regional expertise, with a team specifically supporting customers in Asia. We offer personalized assistance adapted to their products and to the compliance standards of the target market. This includes personalized case-management support for regulatory file submissions with the concerned health authorities to minimize risks of refusal or delay, with the aim of achieving approval quickly and smoothly.Our offer for regulatory support continues beyond approval. We continuously monitor updates to regulations and provide post-commercialization support to our partners to help them manage any necessary regulatory updates.HIGHLIGHTS// Regulatory support offered as premium service/global and regional expertise/personalized case management for faster approvals/continuous regulatory support How does HTL Biotechnology integrate sustainability and corporate responsibility into its operations? Sustainability is embedded in HTL Biotechnology’s strategic vision and day-to-day operations. In 2024, the company renewed its commitment to environmental responsibility by reinforcing its corporate social responsibility (CSR) roadmap. Tangible progress was made across multiple fronts: a 27 percent reduction in greenhouse gas emissions per kilogram of HA produced between 2021 and 2024, and a 34 percent reduction in water consumption per kilogram of HA since 2020. In 2024, we renewed the ISO 14001:2015 certification for its environmental management system, reflecting rigorous audit protocols and continual improvement cycles. All employees have been trained in the ISO 14001-certified environmental management system, and 78 percent of critical suppliers have signed HTL Biotechnology’s Responsible Purchasing Charter.These results reflect HTL Biotechnology’s structured and proactive approach to reducing its environmental footprint while maintaining the highest standards of quality and compliance.HIGHLIGHTS// Sustainability embedded in strategic vision/strong CSR roadmap with measurable progress/reduction in greenhouse gas emissions/responsible sourcing

Impressions: 889

VLOG #PharmaReel

[Sponsored by another company]

A Full-Service API Company

This PharmaReel showcases ChemWerth, a full-service generic API company with over 40 years of experience, offering cGMP-quality APIs through 30+ manufacturing partners across the US, EU, India, and China, backed by 550+ global filings, and expertise in new product development, compliance, and logistics.

Impressions: 1968

DATA COMPILATION #PharmaFlow

[Sponsored by another company]

DMF filings rise 4.5% in Q3 2025; China holds lead, India records 20% growth in submissions

The third quarter (Q3) of 2025 witnessed a steady rise in Drug Master File (DMF) submissions to the US Food and Drug Administration (FDA). DMFs are used to provide confidential, detailed information about facilities, processes, or articles used in the manufacturing, processing, packaging, and storing of human drug productsA total of 323 Type II DMFs were submitted during this period, as opposed to 309 submissions in Q3 2024, marking an increase of 4.53 percent. This is the second highest number since 2018. In Q1 2025, 339 Type II filings were recorded.Across all DMF types (II, III, IV, and V), 479 DMFs were filed in Q3 2025, compared to 394 in Q3 2024, representing a 21.57 percent increase. Out of the 323 Type II DMFs submitted in Q3 2025, 40 had completed their review by the end of Q3, reflecting a processing lag between submission and review completion. View FDA DMF Filings in Q3 2025 (Power BI Dashboard, Free Excel Available)China maintains its lead while India posts double-digit growth in DMF submissions China and India continued to dominate DMF submissions in Q3 2025. China retained the top spot with 153 Type II DMFs, matching its submission count from Q3 2024. India recorded 131 DMFs, marking a 20.18 percent increase over 109 filings during the corresponding period last year.The United States stood a distant third with 17 filings, compared to 13 in Q3 2024. Among European nations, Italy recorded eight DMFs, doubling its 2024 tally. The Netherlands filed four, up from three. Spain submitted only one DMF, as against seven submitted in Q3 2024. Taiwan made three filings, up from one submitted in Q3 2024. Together, India, China and Taiwan accounted for about 88.9 percent of all Type II DMFs filed during the quarter. View FDA DMF Filings in Q3 2025 (Power BI Dashboard, Free Excel Available) China’s Suzhou Ryway Biotech tops corporate tally; India’s Hetero, Biophore followChina’s Suzhou Ryway Biotech led the company-wise tally with 12 DMF submissions in Q3 2025. The company had not filed any DMFs in Q3 2024.India’s Hetero Group followed with nine DMFs, maintaining the same number of filings as Q3 2024. Biophore India Pharmaceuticals ranked third with six DMFs, doubling its count from three last year.Other notable contributors include Sai Sreyas Pharmaceuticals (India) and Shanghai Haoyuan Chemexpress (China), with five DMFs each. Companies such as SNJ Group, Lunan Pharmaceutical, Allsino Pharmaceutical, Shankus Pharma, Jiangxi Xinganjiang Pharmaceutical, Sunpure Extracts, Lee Pharma, Umedica Laboratories, Linhai Tianyu Pharmaceutical and Maithri Drugs filed four DMFs each. View FDA DMF Filings in Q3 2025 (Power BI Dashboard, Free Excel Available) Olaparib, semaglutide lead molecular filings; Dr. Reddy’s files DMF for edoxaban & tucatinibDr. Reddy’s Laboratories also featured among key DMF filers in Q3 2025, submitting two DMFs — for edoxaban tosylate monohydrate and tucatinib copovidone. Edoxaban tosylate monohydrate (marketed as Savaysa by Daiichi Sankyo) is a prescription anticoagulant used to reduce the risk of stroke and to treat deep vein thrombosis and pulmonary embolism. Patent exclusivity for Savaysa extends until October 2026 in the United States, with no generic currently available.In terms of molecules, the highest number of DMFs were filed for olaparib, semaglutide, ruxolitinib phosphate, ferric carboxymaltose, and vismodegib, with three DMFs each in Q3 2025.Olaparib, sold by AstraZeneca under the brand name Lynparza, saw DMFs being filed by BDR Lifesciences and Intas Pharmaceuticals from India, and by ScinoPharm Taiwan during the quarter.Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist developed by Novo Nordisk, continued to draw strong interest from API manufacturers. DMFs for semaglutide were filed by three Chinese companies: Yangzhou Aurisco Pharmaceutical, Zhejiang Peptites Biotech, and Fujian Genohope Biotech.Ruxolitinib phosphate, marketed by Incyte as Jakafi, saw three DMFs. Three Indian companies — Alembic Pharmaceuticals, Valary Labs, and Devi Pharmatech — filed DMFs for this API in Q3 2025. Other molecules that received multiple DMF submissions include ferric carboxymaltose (used to treat iron-deficiency anemia) and vismodegib (an oral therapy for basal-cell carcinoma). View FDA DMF Filings in Q3 2025 (Power BI Dashboard, Free Excel Available) First-time DMF filings span 17 companies; India leads with nine first-time DMFs The quarter saw first-time DMF filings from 17 companies. India took a lead here with nine first-time DMF filings, followed by China (six), and the US (two).The DMF filings in this quarter included inclisiran sodium (filed by Aurisco Pharmaceutical of China), pacritinib citrate (by TAPI Nl B.V. of the Netherlands), and vosoritide (by Apicore LLC of the US).Out of the 19 first-time DMFs filed in Q3 2025, four completed their Generic Drug User Fee Amendments (GDUFA) review process during the quarter. View FDA DMF Filings in Q3 2025 (Power BI Dashboard, Free Excel Available) GDUFA fee for FY 2026: The FDA Generic Drug User Fee Amendments (GDUFA) is a law designed to speed access to safe and effective generic drugs to the public and reduce costs to the industry.Fee rates for fiscal year 2026 were published on July 30, 2025. FDA has revised fees under GDUFA III across all categories. While there is a slight increase in the DMF fee from US$ 95,084 in 2025 to US$ 102,584 in 2026, the ANDA fee has seen a sharp rise: from US$ 321,920 in 2025 to US$ 358,247 in 2026.FY 2025 and FY 2026 User Fee Rates Generic drug fee category Fees rates for FY 2025 Fees rates for FY 2026 Applications: Abbreviated New Drug Application (ANDA) US$ 3,21,920 US$ 3,58,247 Drug Master File (DMF) US$ 95,084 US$ 1,02,584 Facilities: Active Pharmaceutical Ingredient (API)—Domestic US$ 41,580 US$ 43,549 API—Foreign US$ 56,580 US$ 58,549 Finished Dosage Form (FDF)—Domestic US$ 2,31,952 US$ 2,38,943 FDF—Foreign US$ 2,46,952 US$ 2,53,943 Contract Manufacturing Organization (CMO)—Domestic US$ 55,668 US$ 57,346 CMO—Foreign US$ 70,668 US$ 72,346 GDUFA Program: Large size operation generic drug applicant US$ 18,91,664 US$ 19,18,377 Medium size operation generic drug applicant US$ 7,56,666 US$ 7,67,351 Small business generic drug applicant US$ 1,89,166 US$ 1,91,838 Our viewFor several years prior to the pandemic, India had a lead in Type II DMF submissions. In recent years, China has surpassed India in DMF filings. But Q3 2025 numbers indicate that Indian drugmakers are fast catching up. Since DMFs establish trust in APIs from across the world, we feel this healthy competition between drugmakers from the two countries is good for the global pharmaceutical industry.

Impressions: 553

NEWS #PharmaBuzz

[Sponsored by another company]

WHO warns of falsified cough syrup ingredients seized in Pakistan

16 Apr 2024

// REUTERS

UK: EPO Oppositions Newsletter - Surge In Oppositions Matches Surge In Grants

26 Mar 2020

// David Lewin MONKAQ

Takeda's Shire Takeover Seen Facing EU Scrutiny of Drug Research

09 May 2018

// Aoife White BLOOMBERG

Dow's Merck Does An About-Face, Releases Cancer Trial Results

16 Jan 2018

// INVESTORS

DowDuPont completes FMC acquisition, bolsters excipient biz

06 Nov 2017

// Dan Stanton IN PHARMATECHNOLOGIST

Continuous Mfg : suitable excipients & more knowledge required, says Dow

25 Oct 2017

// Flora Southey IN PHARMATECHNOLOGIST

Contact The Dow Chemical Company and get a quotation

The Dow Chemical Company is a supplier offers 79 products (APIs, Excipients or Intermediates).

Find a price of Simethicone bulk with DMF, JDMF offered by The Dow Chemical Company

Find a price of Cholestyramine bulk with JDMF offered by The Dow Chemical Company

Find a price of Dimethicone bulk with JDMF offered by The Dow Chemical Company

Find a price of Amberlite Irp69 bulk with DMF offered by The Dow Chemical Company

Find a price of Cholestyramine bulk with DMF offered by The Dow Chemical Company

Find a price of Lauromacrogol bulk with JDMF offered by The Dow Chemical Company

Find a price of Macrogol bulk with DMF offered by The Dow Chemical Company

Find a price of Simethicone bulk with DMF offered by The Dow Chemical Company

Find a price of XUS43598-SMA Na bulk with JDMF offered by The Dow Chemical Company

Find a price of XUS43598-SMA Ca bulk with JDMF offered by The Dow Chemical Company

Find a price of XUS43598SF Ca bulk with JDMF offered by The Dow Chemical Company

Find a price of Amberlite Irp69 bulk offered by The Dow Chemical Company

Find a price of Aspirin bulk offered by The Dow Chemical Company

Find a price of Cholestyramine bulk offered by The Dow Chemical Company

Find a price of Cyclopropane bulk offered by The Dow Chemical Company

Find a price of Dead On Polystyrene bulk offered by The Dow Chemical Company

Find a price of Decamethylcyclopentasiloxane bulk offered by The Dow Chemical Company

Find a price of Dextropropoxyphene HCl bulk offered by The Dow Chemical Company

Find a price of DPPC bulk offered by The Dow Chemical Company

Find a price of Edetate Sodium bulk offered by The Dow Chemical Company

Find a price of Erythromycin bulk offered by The Dow Chemical Company

Find a price of Erythromycin Stearate bulk offered by The Dow Chemical Company

Find a price of GUANIDINE HYDROCHLORIDE API bulk offered by The Dow Chemical Company

Find a price of Mesalazine bulk offered by The Dow Chemical Company

Find a price of Oxygen bulk offered by The Dow Chemical Company

Find a price of Sevelamer Hydrochloride bulk offered by The Dow Chemical Company

Find a price of Tetracycline bulk offered by The Dow Chemical Company

Find a price of Theophylline bulk offered by The Dow Chemical Company

Find a price of Vinyl Chloride bulk offered by The Dow Chemical Company

Find a price of Xenon Radioisotopes bulk offered by The Dow Chemical Company

Find a price of Zoalene bulk offered by The Dow Chemical Company

Find a price of ZIRCONIA TEXTILES bulk offered by The Dow Chemical Company

Find a price of SILICONE RUBBER DOW CORNING SILASTIC bulk offered by The Dow Chemical Company

Find a price of INVESTIGATIONAL DRUG "MASTER FILE" FOR FUTURE REFS NOTICES T/B SUBMITT bulk offered by The Dow Chemical Company

Find a price of TEFLURANE bulk offered by The Dow Chemical Company

Find a price of POLYTHIOL RESIN bulk offered by The Dow Chemical Company

Find a price of RHOZYME J-25 CONCENTRATE bulk offered by The Dow Chemical Company

Find a price of X7-2837/Q7-2837 SILICONE EMULSION AND REINFORCING AGENT bulk offered by The Dow Chemical Company

Find a price of TERGITOL MONIONIC SURFACTANT 12-M-10 bulk offered by The Dow Chemical Company

Find a price of POLYGLYCOL E-3350 NF bulk offered by The Dow Chemical Company

Find a price of POLYMER JR & LR RESINS bulk offered by The Dow Chemical Company

Find a price of BROMINATED SALICYLANILIDE bulk offered by The Dow Chemical Company

Find a price of HYDROXYETHYL METHACRYLATE 94% bulk offered by The Dow Chemical Company

Find a price of UNION CARBIDE'S SENTRY SIMETHICONE USP & 30% EMUL bulk offered by The Dow Chemical Company

Find a price of 20% OXYGEN, 80% ARGON AS MANUF AT TORRENCIE, CA bulk offered by The Dow Chemical Company

Find a price of UNS-TETRAFLUOROETHANE bulk offered by The Dow Chemical Company

Find a price of MONOCLONAL ANTIBODY CC49 bulk offered by The Dow Chemical Company

Find a price of TERGITOL ANIONIC SURFACTANT 4 bulk offered by The Dow Chemical Company

Find a price of BIO-RELEASE SILICONE RELEASE COATING SYSTEM, HEMLOCK, MI bulk offered by The Dow Chemical Company

Find a price of PZ 5561.21 (DURAFILM PRODUCT) bulk offered by The Dow Chemical Company

Find a price of PROPYLENE GLYCOL--TRADE NAME SIRLENE (VET) bulk offered by The Dow Chemical Company

Find a price of ETHYCELLULOSE DISPERSIONS bulk offered by The Dow Chemical Company

Find a price of FACILITIES IN SHIZOUKA, JAPAN bulk offered by The Dow Chemical Company

Find a price of CHIMERIC (MURINE VARIABLE, HUMAN CONSTANT) MONOCLONAL ANTIBODY (CC49) TO TUMOR ASSOCIATED GLYCOPROTEIN (TAG)-72 bulk offered by The Dow Chemical Company

Find a price of ASPERKINASE PRODUCTION bulk offered by The Dow Chemical Company

Find a price of BIOCRYL, BPA-1000 bulk offered by The Dow Chemical Company

Find a price of SILASTIC 1808 ELASTOMER bulk offered by The Dow Chemical Company

Find a price of SILASTIC 9711 MEDICAL GRADE ELASTOMER bulk offered by The Dow Chemical Company

Find a price of FACILITIES & CONTROLS (METHOXY FLURANE) bulk offered by The Dow Chemical Company

Find a price of UCC MASTER MILKER SYSTEM FOR TC-99 EXTRACTION FROM MO-99 bulk offered by The Dow Chemical Company

Find a price of VINYLITE BRAND COATED PAPER VDI 6645 WHITE 1435 bulk offered by The Dow Chemical Company

Find a price of VERSENE CA. CALCIUM CHELATING AGENT bulk offered by The Dow Chemical Company

Find a price of DISIDIUM DIHYDROGEN VERSENATE, A.R. bulk offered by The Dow Chemical Company

Find a price of SYNTHETIC SODIUM ALUMINOSILICATE ABSORBENTS (MOLECULAR SIEVES) bulk offered by The Dow Chemical Company

Find a price of BIOCRYL BPA-5050PMN bulk offered by The Dow Chemical Company

Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN PITTSBURG, CAL. bulk offered by The Dow Chemical Company

Find a price of ETHOXYLATED POLYETHYLENIMINE, MONTREK 600E bulk offered by The Dow Chemical Company

Find a price of HYAMINE 1622 CRYSTALS (BENSETHONIUM CHLORIDE) bulk offered by The Dow Chemical Company

Find a price of TROLENE FM MEDICATED PREMIX bulk offered by The Dow Chemical Company

Find a price of RHOZYME 41 CONCENTRATE bulk offered by The Dow Chemical Company

Find a price of MURINE MONOCLONAL ANTIBODY (COL-1) TO CEA bulk offered by The Dow Chemical Company

Find a price of BIOCRYL, BPA-1050 bulk offered by The Dow Chemical Company

Find a price of PERSONNEL HANDLING NEW DRUG SUBSTANCES bulk offered by The Dow Chemical Company

Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN MIDLAND, MICHIGAN. bulk offered by The Dow Chemical Company

Find a price of PEI 600 POLYETHYLENIMINE bulk offered by The Dow Chemical Company

Find a price of SILICONE X-251 bulk offered by The Dow Chemical Company

Find a price of DOW 132 (4-TERT-BUTYL-2-CHLOROPHENYLMETHYL METHY PHOSPHORAMIDATE) bulk offered by The Dow Chemical Company

Find a price of HYAMINE X (QUATERNARY AMMONIUM CHLORIDE COMPOUND) bulk offered by The Dow Chemical Company

Find a price of MANUF PROCESSES OF CAP-PLATE MENICON & MAFILCON SOFT CONTACT LENS MAT. bulk offered by The Dow Chemical Company